Related Experiment Video
Updated: Oct 17, 2026

Real-World M3-BREATHE: Toward Multimodal Mobile Monitoring of Behaviour, Respiration, and Exposures for Treatment and Health Evaluation
Published on: June 5, 2026
Infectious, Environmental, and Chronic Disease Burden among 1,844 Newly Arrived Humanitarian Migrants in Oklahoma,
Shelby Beamon1, Sarah Kenney2, Joanna George2
1Department of Family Medicine, The University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
Abstract:
Global displacement has brought increasingly diverse migrant populations into health systems with limited experience managing large-scale humanitarian arrivals, yet contemporary data describing infectious, environmental, and noncommunicable disease burden across heterogeneous newcomer groups remain scarce. A cross-sectional analysis of 1,844 consecutively screened newly arrived individuals who completed the U.S. domestic medical examination at the University of Oklahoma Center for Travel and Immigrant Health between October 2019 and May 2025 was conducted. Screening was performed in accordance with Centers for Disease Control and Prevention Refugee Health Domestic Guidance, with programmatic adaptations. The cohort represented more than 25 countries of origin, with substantial variation across key indicators. Strongyloides stercoralis seropositivity was 14.6% overall, highest among arrivals from Vietnam (27.1%) and Cuba (25.0%). Eosinophilia exhibited low sensitivity (∼12%) for S. stercoralis seropositivity. Elevated blood lead levels (≥3.5 µg/dL) occurred in 19.2% of those tested, concentrated among young Afghan children. Latent tuberculosis infection was identified in 8.9% of patients, with marked country-level gradients. Predeparture antiparasitic therapy coverage was modest (albendazole: 42.2%; ivermectin: 34.2%). Only 6.8% of eligible women had ever undergone cervical cancer screening. Noncommunicable disease burdens varied widely by country of origin. The diverse infectious, environmental, and chronic disease profiles observed across countries of origin highlight the limitations of uniform post-arrival screening. These data support risk-stratified approaches that include targeted infectious disease testing based on country of origin and epidemiological exposures, universal predeparture hepatitis B triple-panel screening, strengthened pediatric lead surveillance, and cancer screening pathways.
Related Concept Videos
Migration
Infectious Diseases and Their Occurrence
Fungal Phylum Microsporidia
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Amebiasis
Reservoir of Infection